Last reviewed · How we verify
NCT03658551: CEDIP-LCI
Intestinal Permeability in Patients With Liver Cirrhosis Using Confocal Endoscopy
trial testing Fluorescein in Cirrhosis, Liver in 15 participants. Terminated before completion.
1 August 2020
Quick facts
| Lead sponsor | Johannes Gutenberg University Mainz |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 1 August 2017 |
| Primary completion | 1 August 2020 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Fluorescein (FLUORESCEIN) — full drug profile →
Conditions studied
- Cirrhosis, Liver — all drugs for Cirrhosis, Liver →
Sponsor
Johannes Gutenberg University Mainz
Who can join
18 and older, any sex, with Cirrhosis, Liver. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The CEDIP LCI study is intended to show the difference in intestinal permeability between compensated and decompensated liver cirrhosis by confocal endoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03658551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fluorescein
Trials testing the same drug.
- NCT07356349 — Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE · Phase 3 · not yet recruiting
- NCT05850520 — A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in · Phase 3 · completed
- NCT05556525 — Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules · NA · terminated
- NCT04687488 — Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations · NA · completed
- NCT03220711 — Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon · NA · terminated
Other recruiting trials for Cirrhosis, Liver
Currently open trials in the same condition.
- NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
- NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
- NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
- NCT07051369 — Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound · active not recruiting
- NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting
Other Johannes Gutenberg University Mainz trials
Trials by the same sponsor.
- NCT06269874 — Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment · NA · not yet recruiting
- NCT07076511 — A Novel Intuitive Airway Trolley for Quick Decision-making in Simulated Unexpected Difficult Airway Situations: Evaluati · NA · completed
- NCT06739993 — Effects of Autonomic Nervous System Modulation by Heart Rate Variability Biofeedback Training With Resonant Frequency Br · NA · recruiting
- NCT06514495 — Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia · NA · recruiting
- NCT07460791 — Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03658551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johannes Gutenberg University Mainz
- Last refreshed: 6 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03658551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing